Hutch News

Hutch News

Stories tagged 'HIV AIDS'

Exploring why people with HIV have a higher risk of lung cancer

120 volunteers to enroll in Seattle-area study of cancer-related gene mutations

Dec. 4, 2018 | By Sabin Russell / Fred Hutch News Service

Researchers Fred Hutch announced on Dec. 1 the start of a new study with a goal to understand why those who are HIV-positive are at higher risk of lung cancer.

View story >


'Cautiously optimistic' about HIV vaccines

A conversation in advance of World AIDS Day with pioneering HIV researcher Dr. Larry Corey

Nov. 30, 2018 | By Sabin Russell / Fred Hutch News Service

In advance of World AIDS Day on Dec. 1, former Fred Hutch President and Director Dr. Larry Corey said he is "cautiously optimistic" about the current HIV vaccine trials. A renowned virologist, Corey has been a pioneer in HIV research since the beginning of the pandemic.

View story >


Study aims to cure blood cancers with transplants that could block HIV, too

10 HIV-positive cancer patients to receive donated cord blood with rare resistance gene

Nov. 16, 2018 | By Sabin Russell / Fred Hutch News Service

Fred Hutch is about to lead a clinical trial offering cord blood transplants to blood cancer patients who also have HIV. The tranplants will carry a genetic trait that naturally confers resistance to HIV, so there is a possibility these transplants might also cure their HIV.

View story >


Gene editing holds promise for shrinking HIV ‘reservoir’

Study mimicking Timothy Ray Brown’s HIV-resistant mutation led to fewer latently infected cells — a key step toward driving the virus into remission without the need for antivirals

April 25, 2018 | By Mary Engel / Fred Hutch News Service

Fred Hutch study shows gene editing holds promise for shrinking HIV "reservoir" — a key step toward driving the virus into remission without the need for antivirals.

View story >


25 powerful years of HIV research

Longstanding Mombasa Cohort helps answer questions about HIV risk and transmission

Feb. 26, 2018 | By Sabrina Richards / Fred Hutch News Service

For 25 years, Fred Hutch virologist Dr. Julie Overbaugh has helped lead the Mombasa Cohort, a unique group of women at high risk for HIV transmission.

View story >


Insights from infants could inform HIV vaccine design

Dr. Julie Overbaugh mines decades-old samples to find new clues to effective immune responses to HIV

Nov. 27, 2017 | By Sabrina Richards / Fred Hutch News Service

Infant immune responses to HIV could provide clues to help build protective or therapeutic HIV vaccines.

View story >



(RSS feeds are best viewed in browsers other than Chrome)

Editor's Picks

GIVE NOW &
SAVE LIVES

Support our quest for cures

Story Archive


Publications

Magazine Archive
Back issues of Hutch Magazine

Financial Reporting
Fiscal highlights & Annual Reports

Science Spotlight
Monthly review of Center-authored papers



Fred Hutch News

        Get updates via email.